Physician profile
Rita A Mankus
NPI 1982623120
$626.03
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $108 · 2021: $19.44 · 2022: $19.45.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Research Incorporated | $315.00 | 2019 | |
| Mallinckrodt Hospital Products INC. | $94.99 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $43.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $38.90 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $38.89 | 2021-2022 | |
| Shire North American Group INC | $32.23 | 2019 | |
| Amgen INC. | $25.13 | 2019 | |
| Mallinckrodt Enterprises LLC | $21.04 | 2019 | |
| Fresenius USA Marketing, INC. | $16.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Mankus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.